Skip to main content
رجوع
AORT logo

Artivion, Inc.

جودة البيانات: 100%
AORT
NYSE Healthcare Medical - Devices
KWD 36.12
▲ KWD 0.42 (1.18%)
القيمة السوقية: 1.73B
نطاق اليوم
KWD 35.44 KWD 36.34
نطاق 52 أسبوعًا
KWD 21.97 KWD 48.25
حجم التداول
221,362
متوسط 50 يوم / 200 يوم
KWD 39.51 / KWD 39.76
الإغلاق السابق
KWD 35.70

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E 177.1 0.2
P/B 3.9 3.0
ROE % 2.7 3.6
Net Margin % 2.2 3.8
Rev Growth 5Y % 10.2 9.7
D/E 0.7 0.2

السعر المستهدف للمحللين

Hold
KWD 52.00 +44.0%
Low: KWD 50.00 High: KWD 55.00
مكرر الربحية المستقبلي
101.15
ربحية السهم المستقبلية
KWD 0.36
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
494.14M

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 1.72
KWD 1.69 – KWD 1.73
787.30M 1
FY2029 KWD 1.33
KWD 1.31 – KWD 1.34
697.90M 1
FY2028 KWD 0.87
KWD 0.76 – KWD 0.97
616.15M 2

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-12 KWD 0.06 KWD 0.17 +203.6%
2025-11-06 KWD 0.14 KWD 0.16 +14.3%
2025-08-07 KWD 0.11 KWD 0.24 +118.2%
2025-05-05 KWD 0.12 KWD 0.06 -50.0%
2025-02-24 KWD 0.12 -KWD 0.39 -425.0%
2024-11-07 KWD 0.10 KWD 0.12 +20.6%
2024-08-08 -KWD 0.49 KWD 0.07 +114.3%
2024-05-06 KWD 0.02 KWD 0.06 +170.3%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

Ex-Date Payment Date Amount Yield
Dec 09, 2015 Dec 18, 2015 KWD 0.03 1.15%
Sep 09, 2015 Sep 18, 2015 KWD 0.03 1.24%
Jun 10, 2015 Jun 19, 2015 KWD 0.03 1.07%
Mar 11, 2015 Mar 20, 2015 KWD 0.03 1.16%
Dec 10, 2014 Dec 19, 2014 KWD 0.03 1.12%
Sep 10, 2014 Sep 19, 2014 KWD 0.03 1.15%
Jun 11, 2014 Jun 20, 2014 KWD 0.03 1.25%
Mar 12, 2014 Mar 21, 2014 KWD 0.03 1.16%
Dec 11, 2013 Dec 20, 2013 KWD 0.03 1.06%
Sep 11, 2013 Sep 20, 2013 KWD 0.03 1.64%
Jun 12, 2013 Jun 21, 2013 KWD 0.03 1.67%
Mar 12, 2013 Mar 21, 2013 KWD 0.03 1.22%
Dec 12, 2012 Dec 21, 2012 KWD 0.03 0.83%
Sep 12, 2012 Sep 21, 2012 KWD 0.03 0.45%

النقاط الرئيسية

Revenue grew 10.24% annually over 5 years — strong growth
ROE of 2.70% is below average
Negative free cash flow of -911,000.0
P/E of 177.06 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3.35%
Capital efficient — spends only 8.85% of revenue on capex

النمو

Revenue Growth (5Y)
10.24%
Revenue (1Y)13.59%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
2.70%
ROIC2.71%
Net Margin2.21%
Op. Margin6.06%

الأمان

Debt / Equity
0.65
Current Ratio2.99
Interest Coverage1.01

التقييم

P/E Ratio
177.06
Forward P/E101.15
P/B Ratio3.86
EV/EBITDA73.16
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 13.59% Revenue Growth (3Y) 11.65%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 10.24% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 441.33M Net Income (TTM) 9.77M
ROE 2.70% ROA 1.10%
Gross Margin 61.28% Operating Margin 6.06%
Net Margin 2.21% Free Cash Flow (TTM) -911,000.0
ROIC 2.71% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.65 Current Ratio 2.99
Interest Coverage 1.01
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 177.06 Forward P/E 101.15
P/B Ratio 3.86 P/S Ratio 3.92
PEG Ratio -1.25 Forward PEG N/A
EV/EBITDA 73.16 Fwd EV/EBITDA 40.63
Forward P/S 3.50 Fwd Earnings Yield 0.99%
FCF Yield -0.05%
Market Cap 1.73B Enterprise Value 1.96B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 441.33M 388.54M 354.00M 313.79M 298.84M
Net Income 9.77M -13.36M -30.69M -19.19M -14.83M
EPS (Diluted) 0.21 -0.32 -0.75 -0.48 -0.38
Gross Profit 270.45M 248.78M 229.18M 202.52M 197.51M
Operating Income 26.75M 38.87M 5.74M 6.20M 8.12M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 884.80M 789.10M 792.40M 762.80M 793.05M
Total Liabilities 436.56M 512.90M 510.62M 478.47M 492.32M
Shareholders' Equity 448.23M 276.20M 281.78M 284.33M 300.73M
Total Debt 292.04M 362.26M 358.34M 356.83M 362.04M
Cash & Equivalents 64.91M 53.46M 58.94M 39.35M 55.01M
Current Assets 303.55M 290.08M 280.67M 247.33M 247.70M
Current Liabilities 101.56M 66.82M 57.86M 49.68M 44.95M